BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

12 articles for P Tapang

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Alpha-keto amides as inhibitors of histone deacetylase.EBI
Abbott Laboratories
Indole amide hydroxamic acids as potent inhibitors of histone deacetylases.EBI
Abbott Laboratories
Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase families.EBI
Abbott Laboratories
 
Synthesis and evaluation of water soluble indole pyrrolothiazole paf antagonistsEBI
TBA
 
Synthesis of active metabolites of indole pyrrolothiazole paf antagonistsEBI
TBA
 
Discovery and optimization of indole pyrrolothiazole paf antagonistsEBI
TBA
Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor.EBI
Abbott Laboratories
Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.EBI
Abbott Laboratories
Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.EBI
Abbott Laboratories
Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonists.EBI
Abbott Laboratories
Heterocyclic GSK-3 allosteric modulatorsBDB
Consejo Superior de Investigaciones Cientificas (CSIC)
Poly (ADP-ribose) polymerase inhibitorBDB
Chengdu Diao Pharmaceutical Group